Tau7.5

Taurine

Taurine

An abundant amino acid with emerging longevity benefits that supports sleep, cardiovascular health, and exercise recovery.

sleeplongevityperformancelongevitysleepheartrecovery
Last reviewed: January 1, 2025
7.5/10
40+ studies
Evidence
high
Safety
1-3g daily
Dose
2-8 weeks
Time to Effect
Powder or capsules
Best Form

Taurine is one of the most abundant amino acids in the body, concentrated in the heart, brain, and muscles. Recent research has highlighted its potential role in longevity, while established benefits include supporting sleep quality, cardiovascular function, and exercise performance.

Mechanisms of Action

🧘
GABA Support

Activates GABA receptors for calming effects

šŸ›”ļø
Antioxidant Defense

Protects cells from oxidative stress

ā¤ļø
Cardiovascular Support

Supports heart function and blood pressure

Recommended Dose

1-3g daily

500mg3000mg

Optimal Timing

  • Pre-workout for performance
  • Evening for sleep

Can be taken without food

Best Form

Powder or capsules

Alternatives: Tablets

Simple amino acid; form doesn't significantly affect absorption. Powder is most economical.

Duration

Minimum: 2 weeks

Optimal: 8 weeks

Cycling: Not required

Note: Flexible timing. Evening for sleep benefits, pre-workout for performance. Can split dose.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

😓
Improved Sleep

Better sleep quality through GABA activation

1-2 weeks
65% of users notice thispositive
šŸ’Ŗ
Faster Recovery

Reduced muscle soreness post-exercise

1 week
70% of users notice thispositive
ā¤ļø
Heart Health

Support for cardiovascular function

4-8 weeks
60% of users notice thispositive
High SafetyMax safe dose: Up to 6g/day used in studies without significant adverse effects
🟔
Pregnant/nursing

Limited data; consult healthcare provider

🟔
Athletes

Not banned; may support performance and recovery

Who Should NOT Take This

  • Bipolar disorder (may affect mood)
  • Epilepsy (may interact with seizure thresholds)

Drug Interactions

Lithiummoderate

May affect lithium levels

Blood pressure medicationsmild

May have additive blood pressure lowering effects

Possible Side Effects

GI discomfortrare

Tip: Take with food

Drowsinessrare

Tip: Take in evening

Warnings

  • Very well tolerated
  • Common in energy drinks but often underdosed
  • Longevity research is emerging but promising

Top studies from 40+ peer-reviewed papers

meta-analysisn=552
DOI

Li J et al. • Nutrients (2025)

ā€œWhile individual supplements may offer limited benefits, synergistic combinations may yield greater improvements in performance and comfort.ā€
Key Findings:
  • Standardized mean differences (SMDs) and posterior probabilities (P-scores based on Bayesian ranking) were calculated using random-effects and Bayesian models.
  • Menthol (SMD = -1.83, 95% CI [-3.15, -0.51]; P-score = 71.04%) and taurine (SMD = 0.91, 95% CI [0.08, 1.73]; P-score = 12.75%) demonstrated significant positive effects on endurance.
  • Menthol energy gel showed the greatest improvement in thermal comfort (SMD = 2.14, 95% CI [1.01, 3.26]; P-score = 99.54%).
rctn=107
DOI

Li F et al. • The American journal of clinical nutrition (2025)

ā€œSupplementation with whey protein powder rich in MFGM, taurine, and B vitamins for 12 mo improve cognitive function in older adults with MCI.ā€
Key Findings:
  • The results also found a significant beneficial effect of the active intervention for several secondary cognitive outcomes such as Digit Symbol Substitution Test score, and the mean difference between groups in the ITT analysis was 2.72 (95% CI: 0.20, 5.23).
  • Few side effects were reported during the study, and there was no statistically significant difference between groups (P = 0.74).
  • Supplementation with whey protein powder rich in MFGM, taurine, and B vitamins for 12 mo improve cognitive function in older adults with MCI.
  • This trial was registered at the https://www.chictr.org.cn/showproj.html?proj=150871 as ChiCTR2200062705.
meta-analysisn=392
DOI

Spillane J et al. • The Cochrane database of systematic reviews (2025)

ā€œMore-recent trials are more robust, and well-conducted RCTs demonstrate moderate-certainty evidence for the efficacy of symptomatic treatments in non-dystrophic myotonias.ā€
Key Findings:
  • Mexiletine likely reduces hand grip relaxation time compared to placebo (mean difference (MD) 1.37 seconds better, 95% confidence interval (CI) 0.87 to 1.86; 2 RCTs, 56 participants; moderate-certainty evidence).
  • There may be no difference in quality of life measures between mexiletine and placebo (36-item Short Form (SF-36) Physical Component Summary (PCS): MD -1.40, 95% CI -5.56 to 2.76; SF-36 Mental Component Summary (MCS): MD -1.10, 95% CI -6.17 to 3.97; 1 RCT, 38 participants; low-certainty evidence).
  • Non-dystrophic myotonia Mexiletine Mexiletine likely reduces myotonia compared to placebo using the Interactive Voice Response Diary Stiffness score (across both treatment periods: MD -3.12, 95% CI -3.75 to -2.49; 2 cross-over RCTs, 89 participants; moderate-certainty evidence).
  • Mexiletine likely improves quantitative hand grip (MD -0.11, 95% CI -0.18 to -0.04; 2 RCTs, 89 participants; moderate-certainty evidence).
meta-analysis
DOI

Deng H et al. • Journal of the International Society of Sports Nutrition (2025)

ā€œCAF+TAU co-supplementation provides a balanced ergogenic effect, combining the central stimulation of CAF with the neuromodulatory and metabolic support of TAU, particularly beneficial for high-intensity, reaction-based tasks.ā€
Key Findings:
  • Posterior estimates indicated that CAF+TAU was associated with a credible positive effect on anaerobic capacity (g = 0.46, 95% CrI [0.19, 0.71]) and reaction time (g = 0.75, 95% CrI [0.29, 1.18]) compared to CAF or TAU alone.
  • CAF showed the greatest posterior reduction in RPE (g = -0.64, 95% CrI [-1.20, -0.10]), while its posterior mean estimate suggested a potential increase in B[la] (g = 0.24, 95% CrI [-0.48, 0.96]).
  • In contrast, TAU showed a possible tendency toward reducing B[la] (g = -0.30, 95% CrI [-1.01, 0.42]).
meta-analysisn=402
DOI

Cao Q et al. • International journal of food sciences and nutrition (2025)

ā€œOverall, the findings of the present meta-analysis do not provide sufficient evidence to support the efficacy of taurine supplementation in enhancing cognitive function.ā€
Key Findings:
  • A total of 7 RCTs with 9 intervention trials involving 402 individuals were included.
  • Taurine, administered alone or in combination with exercise training, did not exhibit significant effects in cognitive scores.
  • Overall, the findings of the present meta-analysis do not provide sufficient evidence to support the efficacy of taurine supplementation in enhancing cognitive function.
40
Total Studies
9.1/10
Avg Quality
12-11,966
Sample Size Range
2007-2025
Research Span

Study Type Distribution

Meta-Analysis
24
RCT
8
Systematic Review
6
Observational
1
Crossover
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.